[Characteristics of patients with drug-resistant epilepsy in a tertiary hospital].

Autor:	Iglesias-Rodríguez M; Hospital Universitario San Pedro, Logroño, España., Navarro-Abia V; Hospital Universitario de Burgos , Burgos, España., Barbadillo-Mariscal B; Hospital Universitario de Burgos , Burgos, España., Gil-Calderón FJ; Hospital Universitario de Burgos , Burgos, España., Gonzalo-San Esteban A; Hospital Universitario de Burgos , Burgos, España., Mañaricua-Arnaiz A; Hospital Universitario de Burgos , Burgos, España., Tejero-Pastor L; Hospital Universitario de Burgos , Burgos, España., Conejo-Moreno D; Hospital Universitario de Burgos, Burgos, España.
Jazyk:	Spanish; Castilian
Zdroj:	Revista de neurologia [Rev Neurol] 2024 Nov 16; Vol. 79 (10), pp. 273-277.
DOI:	10.33588/rn.7910.2024321
Abstrakt:	Introduction: Drug-resistant epilepsy has a cumulative incidence between 14 and 20% of patients with epilepsy. It is associated with more comorbidities and with higher healthcare expenditure and impact on quality of life. Patients and Methods: A retrospective longitudinal descriptive study was performed covering the period from 01/01/2010 to 02/28/2024. All patients with epilepsy seen in the Pediatric Neurology unit of our center were collected and a review of medical records was carried out to collect the characteristics and evolution during the study period. The classification and definitions used were those established by the International League Against Epilepsy. Results: A total of 325 patients with epilepsy were identified, with a cumulative incidence of DRE of 29%. The most frequent etiology was structural both in all patients with epilepsy (22%), and in drug-resistant epilepsy (36%). A statistically significant association was established between refractoriness and genetic and structural causes, and between having status epilepticus and the development of drug-resistant epilepsy. Seventy-nine percent of patients with drug-resistant epilepsy developed epileptic encephalopathy. The most commonly used antiseizure drug was valproic acid (90%), 19% received a ketogenic diet and 4.2% received epilepsy surgery. Conclusions: In our setting the incidence of drug-resistant epilepsy is high, more so than previously described. Genetic and structural etiologies are associated with a higher incidence. Having suffered status epilepticus is associated with refractoriness. A higher incidence was observed in patients with defined electroclinical syndromes, probably influenced by epileptic and developmental encephalopathies.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu